Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


Catalog Number Pack Size List Price* Quantity
HY-136531-5MG 5 mg Inquire
HY-136531-50MG 50 mg Inquire
HY-136531-100MG 100 mg Inquire
HY-136531-10MG 10 mg Inquire

* CHF, excl. 7.7% VAT and shipping costs

Product Description

XMU-MP-3 is a potent non-covalent BTK inhibitor with IC50s of 10.7 nM and 17.0 nM for BTK WT and BTK C481S mutation in the presence of 10 μM ATP, respectively. XMU-MP-3 also induces apoptosis.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Grade Clinical information: No Development Reported
Molecular Formula C27H27F3N8O
Molecular Weight 536....
CAS-Number [2031152-08-4]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support

Business Development

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern


If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.

© Copyright 2021 Lucerna-Chem AG, Switzerland